Device for malaria prevention in high-risk areas
Part of Infections clinical trials.
This study tests a device called the Guardian Spatial Emanator, which may help prevent malaria. It is being added to an existing program that distributes antibiotics to reduce infections in high-malaria areas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your household must be in an area covered by the AVENIR II program (a health program giving antibiotics to prevent infections).
- You must live in a region where malaria is common.
- Your household must be chosen randomly by the study team.
- You and the local health clinic chief must both agree to take part.
- Your household must be within a selected health clinic's service area.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a long-acting mosquito repellent that could help prevent malaria. It is for children living in the study area, and simply involves letting us know if your child is home for a visit.
This Phase 3 trial tests whether giving malaria medicine to people in high-risk households (a “mass drug administration” campaign) can stop local relapses and eliminate vivax malaria. If you live close to a recent malaria case, you may be offered a preventive dose, based on age and medical safety checks.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This study tests two different malaria vaccines to see which is safer and works better. Participants will receive one of the vaccines and then be exposed to a safe form of the malaria parasite to check if it protects them.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
This study tests if giving schoolchildren malaria-prevention medicine at certain times can lower malaria in the community. It might help protect your child and others from getting sick.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.